Destra Multi-Alternative Fund Announces Distribution Increases
|
June |
July |
August |
DMA |
|
|
|
Payment Date |
|
|
|
Record Date |
|
|
|
“We are thrilled that the Fund’s
“We have been moving more of the portfolio into our hedged strategies, utilizing our Validex Dynamic Alpha process and it has generated encouraging results,” said
The Fund offers a Dividend Reinvestment Plan (“DRP”). Shareholders who hold their shares at a broker dealer and would like to participate in the DRP should contact their broker dealer to set their reinvestment preferences. Shareholders who hold their shares directly with the Fund will have all dividends declared on the shares automatically reinvested in additional shares by the Fund’s plan agent,
A portion of each distribution may be treated as paid from sources other than net investment income, including but not limited to short-term capital gain, long-term capital gain, or return of capital. As required by Section 19(a) of the Investment Company Act of 1940 and Rule 19a-1 thereunder, a notice will be distributed to shareholders in the event that a portion of a monthly distribution is derived from sources other than undistributed net investment income. The final determination of the source and tax characteristics of these distributions will depend upon the Fund’s investment experience during its fiscal year and will be made after the Fund’s fiscal year end. The Fund will send shareholders a Form 1099-DIV for the calendar year that will define how to report these distributions for federal income tax purposes, but shareholders should consult their own tax advisers regarding their specific tax situations and to obtain a complete understanding of the tax consequences. For further information regarding the Fund’s distributions, please visit www.destracapital.com.
About
About
Shares of the Fund can be purchased on the
Information regarding the Fund and
Please contact
View source version on businesswire.com: https://www.businesswire.com/news/home/20250519215408/en/
DMA@destracapital.com
(877) 855-3434
Source: